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SUMMARY 
Prospective epidemiological studies from 1980 to 1989 accumulated evidence 
of a possible relationship between cardiovascular disease and plasma 
fibrinogen concentration. It was soon evident that raised fibrinogen levels, 
causing hypercoagulable states, involve complex and multifactorial processes·. 
Consequently it is important to realise that hypercoagulability is associated 
with other risk factors of cardiovascular disease. This elevates the increasing 
importance of studying the haemostatic variables together with these risk 
factors. 
It is suspected however, that not only fibrinogen concentration, but also the 
quality of fibrin networks may contribute to coronary heart disease risk. It is 
known that other modulating factors in blood also affect the network structures 
as they are formed with otherwise constant fibrinogen and thrombin 
concentrations. Previous research extensively studied modulating factors 
such as albumin, glucose, smoking and diabetes. 
Socially patterned accumulation of health capital and cardiovascular risk 
begins in childhood. In the Whitehall II longitudinal study conducted by 
Brunner, adult occupational position was inversely associated with fibrinogen, 
other metabolic risk factors and risk factors like leisure time physical inactivity. 
Childhood, social position was associated with adult fibrinogen levels. 
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The objective of this study was to determine the association between fibrin 
network architecture and socio-economic status in adult women. Three 
groups of adult women representing different socio-economic backgrounds 
were chosen randomly to voluntarily participate in the study. The study 
groups consisted of 27 white women (employees of the TFS), 30 "urbanized" 
black women (women living in an urbanized area for more than thirty years), 
and 30 "less urbanized" black women (women living in an urbanized area for 
less than thirty years). 
Fasting blood samples were taken on the premises of the Technikon Free 
State by a registered nurse and volunteers had medical examinations by a 
registered general practitioner. Fibrin network architecture variables and 
plasma fibrinogen were determined on fresh essentially platelet free plasma 
by standardised laboratory techniques. Other metabolic variables were 
performed on serum and full blood counts were performed on EDT A whole 
blood using standardised laboratory techniques. 
Results indicated that a association between socio-economic status and 
haemostatic profiles do exist. Many of the differences in analytical variables 
however, were expected and due to other relating factors such as ethnicity. 
The mean fibrinogen level of the white group of women was 3.S4±0.24 gIL. 
The group of black women defined as "less urbanized" displayed lower mean 
fibrinogen levels (3.16±.0.19 gIL) . In contrast, the levels of the "urbanized" 
black women were much higher (4.04±0.22 gIL) . However, these differences 
were not significant. This confirms the effect of urbanization and thus socio-
IV 
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economic status on plasma fibrinogen levels. Small differences were 
observed between network fibrin content and fibrinogen levels, and between 
mass length ratio and fibrinogen levels in all three the groups. It was 
unknown if these differences were static or in the process of development and 
an indication of future tendencies. Except for total protein values no 
significant differences were found between metabolic variables. This was 
expected as very strict inclusion/exclusion criteria were used to ensure that all 
volunteers were "apparently" healthy. 
This study in a way contradicts the hypothesis that socio-economic class itself 
may be the main cause of differences in some metabolic parameters from 
individuals within different levels of socio-economic backgrounds seeing as 
such strict exclusion criteria were used. It is believed that the factors related 
to the different levels of socio-economic status, such as the prevalence of 
tuberculosis, HIV, diabetes mellitus, hypercholesterolaemia, may play an 
important role in the outcome of the health status of the individuals within 
different levels of society. This study implies that the metabolic variables 
associated with different levels of socio-economic status are not necessarily 
associated with socio-economic class itself, but rather with the associated 
factors related to the different levels of socio-economic status. The study 
group was also very small which might have contributed to the lack of 
significance between groups. This study emphasises the need for prospective 
epidemiological trails to evaluate the true effect of socioeconomic variables 
and associated conditions on metabolic risk factors. 
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OPSOMMING 
Epidemiologiese studies wat gedoen is vanaf 1980 tot 1989 het bewyse 
versamel van 'n moontlike verwantskap tussen kardiovaskuh~re siektes en 
plasmafibrinogeenkonsentrasie. Oit was gou duidelik dat verhoogde 
plasmafibrinogeenvlakke, wat hiperstolbaarheids toestande veroorsaak, 
komplekse en veelvuldige prosesse behels. Oit is dus belangrik om te besef 
dat hiperstolbaarheid geassosieer kan word met ander risikofaktore van 
kardiovaskulere hartsiektes. Oit beklemtoon dan die toenemende 
belangrikheid van studies wat beide haemostatiese veranderlikes en hierdie 
risikofaktore behels. 
Oaar word egter vermoed dat dit nie net die fibrinogeenkonsentrasie is wat tot 
die risiko vir koronere hart siektes bydra nie, maar ook die kwaliteit van 
fibriennetwerke. Oit is wei bekend dat daar moduleerende faktore in bloed is 
wat 'n invloed kan he op die netwerk strukture, wanneer hul vorm by 
andersins konstante fibrinogeen en trombienkonsentrasies. Sommige van 
hierdie moduleerende faktore is al ekstensief ondersoek, van die faktore sluit 
in by. rook, glukose, albumien, diabetes ens. 
'n Patroon van sosiale versameling van rykdom, kapitaal en kardiovaskulere 
risiko begin reeds as kind al vorm. In die Whitehall " studie onder lei ding van 
Brunner is volwasse beroeps posisie omgekeerd geassosieer met fibrinogeen, 
ander metaboliese risikofaktore en risikofaktore soos fisiese onaktiewiteit in 
ontspannings tyd. 
VI 
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Die doel van die studie was om te bepaal of daar 'n verwantskap bestaan 
tussen die sosio-ekonomiese status en fibrien netwerk argitektuur in volwasse 
vroue. Die studie populasie het bestaan uit drie groepe volwasse vroue 
verteenwoordigend van verskillende sosio-ekonomiese agtergronde. Die 
proefpersone was almal vrywiligers en is lukraak gekies. Die groepe was 
sewe en twintig blanke vroue (werknemers van die Technikon Vrystaat), dertig 
"verwesterde" swart vroue (vroue wat al langer as dertig jaar in 'n stedelike 
gebied woon), en 30 "minder verwesterde" vroue (vroue wat vir minder as 
dertig jaar in 'n stedelike gebied woon). 
Vastende bloed monsters is deur 'n geregistreerde verpleegkundige versamel 
op die gronde van die Technikon Vrystaat, en 'n geregistreede algemene 
praktisyn het 'n mediese ondersoek op al die vrywiligers uitgevoer. 
Fibriennetwerk struktuur veranderlikes en plasmafibrinogeenkonsentrasies is 
bepaal op vars issensieel plaatjie vrye plasma deur gestandardiseerde 
laboratorium tegnieke te gebruik. Ander metaboliese veranderlikes is op 
serum uitgevoer, en volbloedtellings is op EDTA heelbloed uitgevoer met die 
gebruik van gestandardiseerde laboratorium tegnieke. 
Resultate wys dat daar 'n verwantskap bestaan tussen die sosio-ekonomiese 
status en haemostatiese profiele. Baie van hierdie verskille in die 
haemostaties analiete was egter te wagte, en as gevolg van ander verwante 
faktore 5005 etnisiteit. Die median fibrinogeevlakke van die groep blanke 
vroue was 3.54 ± 0.24 gIL. Die groep swart vroue beskryf as "minder 
verwesterd" het laer median fibrinogeenvlakke getoon (3.16 ± 0.19 gIL), in 
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teenstelling hiermee was die vlakke van die groep ' verwesterde" swart vroue 
baie hoer (4.04 ± 0.22 gIL) . Hierdie verskille was egter nie betekenisvol nie, 
maar dit bevestig die effek van verwestering en dus sosio-ekonomiese status 
op plasma fibrinogeen vlakke. Klein verskille is waargeneem tussen netwerk 
fibrien inhoud en fibrinogeen vlakke, en tussen massa-Iengte verhouding en 
fibrinogeen vlakke in al drie die groepe. Oit was nie bekend of die verskille 
staties was of in die proses van ontwikkeling was as 'n indikasie van 
toekomstige neigings nie. AI die metaboliese veranderlikes het geen 
betekenisvolle verskille getoon nie met die uitsondering van totale proteine. 
Oit was te wagte siende dat baie streng insluitings/uitsluitings kriteria gebruik 
is om seker te maak dat aile proefpersone "oenskynlik" gesond was. 
Die studie weerspreek tot 'n sekere mate die hipotese dat sosio-ekonomiese 
klas self die hoof oorsaak kan wees vir verskille in sommige metaboliese 
veranderlikes van individue met verskillende sosio-ekonomiese agtergronde 
na aanleiding van die steng uitsluitings kriteria wat gebruik is in hierdie studie. 
Oit word verwag dat faktore verwand aan verskillende vlakke van sosio-
ekonomiese status soos die voorkoms van tuberkilose, HIVNIGS, diabetes 
mellitus, hipercholesterolemie ens., 'n belangrike rol kan speel in die uitkoms 
van gesondheidsstatus van die individue in die verskillende vlakke van die 
gemeenskap. Hierdie studie impliseer dat metaboliese veranderlikes wat 
geassosieer word met sosio-ekonomiese status nie noodwending met sosio-
ekonomiese klas self geassosieer word nie, maar eerder met geassosieerde 
faktore verwant aan die verskillende vlakke van sosio-ekonomiese status. Die 
studie groep was ook baie klein gewees wat kon bydra tot die beperkinge in 
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die interpretasie van die resultate. Die studie benadruk die belangrikheid van 
voornemende epidemiologiese ondersoeke om die effek van sosio-
ekonomiese veranderlikes en geassosieerde toestande op metaboliese 
risikofaktore te evalueer. 
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CHAPTER 1 
INTRODUCTION 
1.1 Background 
Raised plasma fibrinogen is accepted as an important risk factor for coronary 
heart disease (CHD), atherosclerosis, and stroke (Kannel et al., 1987; 
Meade et al.,1986; Stone & Thorpe, 1985; Wilhelmsen et aI., 1984; Yarnell 
et aI. , 1991). 
It is suspected, however, that not only fibrinogen concentration, but also the 
quality of fibrin networks may contribute to CHD risk (Blomback et aI., 1992). 
It has also been shown that fibrin network structure can be directly affected 
by the fibrinogen concentration (Nair et aI., 1991a). 
Knowledge of the structure of fibrinogen and of the properties of the fibrin 
polymers that are formed on activation of fibrinogen by thrombin or other 
enzymes has expanded considerably during the past decade. Evaluation of 
fibrin network properties has become easy and accessible in almost any 
standard laboratory. Methods based on turbidity and permeability have 
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become available for measurement of fibrin network structure properties 
(Nair et aI., 1991 a). 
Altered fibrin network structures are believed to play an important role in the 
development of CHD and thrombosis (Blomback et aI., 1992). When 
examining cardiovascular risk, it is important to remember that fibrin 
concentration is an important risk factor, but there are many other aspects to 
consider, such as the complex relationship between fibrinogen and other risk 
factors producing altered network structures (Blomback et aI., 1992). When 
thrombin and fibrinogen interact to generate fibrin monomers, the 
concentrations of both fibrinogen and thrombin play an important role in the 
fibrin network structure (Blombiick et aI., 1990). It was also found that 
clotting time is directly related to the gel structures of fibrinogen, thus events 
preceeding gel formation determine the gel structure (Blomack et aI., 1982). 
In a purified fibrinogen-thrombin system, under static condition , the gel structure 
is mainly determined by kinetic factors, i.e. the thrombin (Hantgan & 
Hermans, 1979) and fibrinogen concentrations (Donovan & Mihalyi, 1985; 
Hortin & Trimpe, 1991). Together these factors create the clotting potential. 
There are other factors that at the same clotting potential can modulate the 
network without perturbation of the general architecture. These modulating 
factors change the architecture of the network by either interacting with the 
water in the medium during fibrin formation or by binding to either fibrinogen 
2 
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or to the fibrin strands in the established network. Some of these modulating 
factors have been studied extensively in the past such as fibrinogen 
composition (Fatah et al., 1992), albumin (Galanakis et aI., 1987), cations, 
pH and temperature (Nair et aI., 1986), blood platelets (Van Gelder et aI., 
1993), plasma antithrombin-III (AT) (Elgue et aI., 1994), dextran (Carr & 
Gabriel, 1980), glucose and antidiabetic drugs (Azhar et aI., 1990), 
fibronectin (Nair et ai, 1991a) and social class (Markowe et al,. 1985). 
These modulating factors have remarkable effects on fibrinogen 
concentration in humans. This indicates directly that an associated effect on 
fibrin network architecture is evident (as described earlier, fibrinogen is a 
kinetic regulator of fibrin network architecture). 
A variety of studies have indicated a definite relationship between plasma 
fibrinogen concentration and fibrin network architecture in human subjects. 
It has been shown that socio-economic status may have a direct effect on 
fibrinogen concentration, and associated cardiovascular risk. Little is 
known, however, about the relationship between fibrin gel properties and 
socio-economic status. 
1.2 Hypothesis 
The hypothesis tested in this study states that: 
3 
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- H1 socio-economic status will have a direct effect on fibrin network architecture 
in female human subjects. 
- Ho socia-economic status will not have a direct effect on fibrin network 
architecture in female human subjects. 
1.3 Objectives 
The main objective 
The main objective of this study was to investigate the association between 
socia-economic status and fibrin network architecture in female subjects aged 
between 35 and 44 years of age. 
The sub-objectives 
The sub-objectives of the study were: 
- to identify population groups with different socia-economic status 
- to determine the prevalence of some cardiovascular risk factors, including fibrin 
network architecture variables in the defined population groups. 
4 
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1.4 Structure of this dissertation 
The structure of this thesis is as follows: 
Chapter 2 is an extensive literature survey in which the most critical information 
needed to understand and interpret the hypothesis and results of this study is 
discussed. Chapter 3 provides detailed information about specimen preparation 
and all test procedures used in the study. The results for all tests are given in 
Chapter 4. Finally, in Chapter 5 the results, conclusion and recommendations 
made from this study are discussed. 
5 
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Plasma fibrinogen - Introduction 
Over the last 20 years, an increasing amount of evidence has been published 
demonstrating that the plasma fibrinogen level has a major impact on 
arterial disease of the heart, brain, and limbs. This evidence comes from 
epidemiological, pathophysiological and clinical studies. These studies 
include the Northwick Park Heart Study (Meade et aI., 1986), the 
G6teborg Study (Wilhelmsen et aI., 1984), and the Framingham Study 
(Kannel et aI., 1987). 
Fibrinogen is a high molecular weight glycoprotein (340,000 Oa) which 
circulates in plasma at concentrations between 1.5 and 4.5 gn. It is 
absent from serum, which is defibrinated plasma. Plasma fibrinogen has 
a half-life of approximately 100 hours. It's routes of catabolism are poorly 
defined, and known fibrinolytic pathways contribute little to its removal 
from the circulation. Fibrinogen crosses vascular endothelium both into 
the arterial wall and, through the microcirculation, into the tissues in 
inflammatory states, in which fibrin participates. 
6 
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Traditionally, clinical interest in fibrinogen has been from haematologists 
dealing with bleeding disorders. Soluble fibrinogen is the precursor of 
insoluble fibrin, which is an important component of the haemostatic plug 
that develops after vascular injury. The minimum plasma fibrinogen level 
for haemostasis is 0.5 - 1.0 gil. Low fibrinogen levels are associated with 
excessive bleeding after injury or surgery, in both rare congenital 
afibrinogenaemias and disfibrinogenaemias, and, more commonly, severe 
acute or chronic liver diseases due to reduced hepatic synthesis. 
Transient low fibrinogen levels may be associated with excessive 
bleeding in overt disseminated intravascular coagulation (DIC), primary 
pathological hyperfibrinolysis, and thrombolytic and defibrinating enzyme 
therapy (Lowe, 1993). 
Fibrinogen is involved in acute-phase protein reactions to injury, surgery, 
acute infections and infarctions. Within a few hours of these events, 
hepatic synthesis of fibrinogen and other acute-phase proteins increase, 
probably due to hepatocyte stimulation by fibrin degradation products 
and/or activated monocytes (which produce cytokines such as interleukin-
6) from damaged tissues. Such protein reactions presumably playa role 
in haemostasis and in inflammation after tissue injury (Dippel, 1992). 
Plasma fibrinogen levels usually peak at 2-4 times basal levels after 3-5 
days, then gradually retum to basal levels with resolution of inflammation. 
Plasma fibrinogen levels are chronically elevated in chronic infections, in 
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chronic inflammatory diseases such as rheumatoid arthritits, and in 
malignant diseases. Since it is a large, elongated molecule, increases in 
fibrinogen result in elevated plasma viscosity and increased red blood cell 
aggregation (e.g. an elevated erythrocyte sedimentation rate, ESR). Both 
plasma viscosity and the ESR are used to monitor plasma protein 
reactions as measures of disease activity (Lowe, 1993). 
2.2 Synthesis and secretion of fibrinogen 
Human fibrinogen (Figure 2.1) is a dimetric multichain protein. Each identical 
half molecule is composed of three distinct polypeptides (Aa, B!3, and V), 
synthesised primarily in the liver (Roy et at, 1992). The two half 
molecules are joined together by symmetrical disulfide bonds between two 
Aa and two y chains (Cook & Ubben, 1990). In addition, fibrinogen has a 
number of inter- and intrachain disulfide bonds. There are 29 in all, with 
no free cysteine residues (Roy et at, 1992). Each fibrinogen chain is 
encoded by a separate gene, and synthesised in the granular 
endoplasmatic reticulum (Hartwig & Danishefsky, 1991). 
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Figure 2.1 A molecular model of the Fibrinogen Molecule, as adopted from 
Doolittle (1981) 
Hepatocytes are the principle site of synthesis of fibrinogen, and are 
controlled by hepatocyte stimulating factors (HSF) secreted by activated 
monocytes. Monocytes are activated by the products of fibrinolysis to 
produce cytokines (Wang & Fuller, 1991). At least three cytokines, 
interleukin-6, leukemia inhibitory factor, and oncostatin M contribute to 
HSF activity (Rose & Bruce, 1991). Both the V and the Aa chain are 
stored in cells (Roy et al., 1992) and released together by the Golgi cells 
when needed (Danishefsky et aI., 1990). BI3 chains of the fibrinogen 
molecule cannot be stored, and are immediately used after translation (Yu 
et al. , 1984). 
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2.3 Molecular structure of fibrinogen 
Models of the fibrinogen molecule suggest that it is a long, slightly bent and 
coiled trinodular dimeric molecule of 340 000 Daltons (Hartwig & 
Danishefsky, 1991 ; Torbet, 1986). The molecule is simplistically to be 
perceived as a cylinder of 7 x 48 nm. The amino-termini of the six 
subunits form the E domain. This domain is central to the COOH-termini , 
which forms the two D domains (Dang & Bell, 1989). The E domain is 
linked to the two D domains by a coiled-coil triple helix structure of 111 
amino acids (Huang et al., 1993). Disulfide rings border each of the 
coiled-coil regions of the molecule and link the tree chains of the half-
molecule (Blomback et at, 1968). Disulfide bonds at the amino-terminal 
region of the a and V chains hold the two a!3v half-molecules together 
(Hoeprich & Doolittle, 1983). Disruption of these disulfide rings leads to 
the formation and secretion of two half-molecules (Zhang & Redman, 
1994). Additional to this, another 29 disulfide bonds functional within the 
chains, exist in the molecule (Roy et at, 1992). Disruption of these 
interchain disulfide bonds at the COOH-terminal end of the coiled-coil 
region allows dimer formation, but the 6-chain molecule which is 
assembled is not secreted (Zhang & Redman, 1994). 
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2.4 Fibrinogen in blood coagulation and fibrinolysis 
2.4.1 Blood coagulation 
The conversion of fibrinogen to fibrin by protease thrombin is the final step in 
the coagulation process. Coagulation can be regarded as a cascade-like 
amplifying reaction, in which most coagulation factors (factor xii, x, ix, vii 
and ii) have an enzymatic function in their activated form. Fibrinogen 
serves as a substrate in this process (Figure 2.2). 
The plasma protein fibrinogen is converted to the insoluble fibrin matrix of 
blood clots by a multi-step process (Roy & Hermans, 1979). The 
fibrinogen molecule comprises of 2 Aa-, 2 BI3-, and 2 y-polypeptide chains 
(Roy et al., 1992). It undergoes limited proteolysis and aggregation. 
Fibrin assembly is a highly ordered process which is initiated by thrombin-
catalyzed hydrolysis at Arg-A 16 to form fibrin I monomer and releases a 16 
aminoacyl residue peptide (fibrinopeptide A) from the N-terminus of each 
Aa-chain (Lewis et aI., 1985). This process is followed by the end-to-end 
aggregation of the fibrin I monomers, resulting in the formation of fibrin I 
oligomers (protofibrils). This step causes lengthening of the fibrin strands. 
The fibrin protofibrils associate laterally (Roy et aI., 1979) and is then 
followed by thrombin-mediated hydrolysis at Arg-B1314 to form fibrin II and 
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release a 14-aminoacyl residue peptide (fibrinopeptide B) from the amino 
terminus of each of the Bj3-chains (Lewis et aI., 1985). This step causes 
thickening of the fibrin strands. The resulting fibrin II protofibrils have a 
greater propensity than fibrin I protofibrils to undergo lateral interaction 
which will result in fiber formation of the fibrin network. 
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Figure 2.2 Blood coagulation and fibrinolysis (Dippel, 1992) 
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2.4.2 Fibrinolysis 
Fibrinolysis, a specific process leading to solubilisation of fibrin formed , plays 
a key part in the natural antithrombotic mechanism (Gandrille & Aiach, 
1990). The blood clotting system, both anabolic and catabolic, has been a 
subject of great interest for some years, and more so now with the higher 
incidence of cardiovascular heart disease. 
Plasmin is a protease capable of digesting both fibrinogen and formed fibrin 
structures. Plasmin normally exists in its inactive form, plasminogen, in 
plasma. Plasminogen activation to plasmin is the first important step in the 
fibrinolytic process. There are various types of activators found in the 
body, but the most important one known being tissue plasminogen 
activator (tPA) . 
Neither fibrinogen nor monomeric fibrinogen influences the tPA mediated 
conversion of plasminogen, but after thrombin mediated transformation of 
fibrinogen to fibrin oligomers, a strong stimulation of the tPA activity can 
be observed (Gn15 n et al., 1992). Consequently, on a mole to mole basis, 
fibrin oligomers are more powerful than fibrin monomers as stimulators of 
tPA activity (Gnlln et aI., 1992). 
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Polymeric fibrin is a strong enhancer of the activation of plasminogen by tPA. 
At least two types of sites are involved in this enhancement, i.e. a site 
within Aa-(14B-160), and a site within y-(311-379). These sites are not 
accessible in fibrinogen but are exposed upon conversion of fibrinogen to 
fibrin (Nieuwenhuizen, 1994). The adsorption of tPA and plasminogen on 
the fibrin fiber surface allows the necessary contact needed to affect 
optimal activation rates for plasmin production and spatial proximity of the 
fibrin substrate. Thus the fibrin plays a dual role, not only does it enhance 
tPA activation, but it also acts as a substrate for plasmin (Gabriel et aI., 
1992). 
According to Gabriel et al. (1992) the fibrin structure also contributes to the 
regulation of the fibrinolytic rate. This explains the influence that albumin 
has on fibrinolysis seen as it also modifies clot structure, and facilitate 
further plasminogen uptake by preformed clots (Grandrille & Aiach, 1990). 
Inhibition of the firinolytic system can be accomplished by the actions of a 
-antiplasmin-2, plasminogen activator inhibitors and the fibrinogen 
molecule. 
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2.5 Fibrinogen as a risk marker for CHD 
It is evident that raised fibrinogen levels, causing hypercoagulable states, 
involve complex and multi-factorial processes (Figure 2.3). According to 
Tarallo et al. (1992) the known risk factors for cardiovascular disease explain 
nearly 15% of the total variance in fibrinogen concentration. 
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Figure 2.3 Summary of potential mechanisms by which increasing plasma 
fibrinogen levels may promote arterial disease and ischaemic 
events. LDL = low density lipoprotein (Lowe, 1993) 
During the years 1980-1989, results were reported from four prospective 
epidemiological studies of fibrinogen as a possible risk factor for 
cardiovascular disease. These studies included the Gbteburg Study 
(Wilhelmsen et aI., 1984), the Northwick Park Heart Study (Meade et aI., 
1986), the Framingham Study (Kannel et aI., 1987) and the Leigh Clinical 
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Research Unit Study (Stone & Thorpe, 1985). The association between 
fibrinogen level and cardiovascular disease was present in all four of these 
studies. On the basis of their results, all the authors of these studies 
concluded that a high fibrinogen level was an independent risk factor for 
cardiovascular disease, and that fibrinogen plays an especially important role 
in the thrombotic processes in the pathogenesis of cardiovascular disease. 
Fibrinogen is accepted as an independent risk factor for cardiovascular disease. 
It would therefore be of great importance, from both a scientific and 
preventive point of view, to know what factors influence fibrinogen levels. 
2.5.1 Hypercholesterolaemia 
A study on groups of men of similar mean age in communities of very low 
(Gambia), high (England and Czechoslovakia) and very high (Scotland and 
Finland) risk of ischaemic heart disease (lHD), showed a consistent gradient 
of higher cholesterol levels associated with higher fibrinogen levels. 
Consequently this association indicates that subjects with high cholesterol 
levels could even be more prone to development of IHD if high fibrinogen 
levels are present as well (Meade et aI., 1986). 
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2.5.2 Dislipidaemia 
In a study performed on healthy men it was shown that elevated fibrinogen 
concentrations of >2.90 gIL were associated with increased levels of 
circulating small, dense LDL particles and reduced HDL cholesterol. Serum 
triglycerides and concentrations of triglyceride-rich lipoprotein particles 
(VLDL) were also higher (Halle et al., 1996). This was also the conclusion of 
Simpson in a study on 18 patients with severe hypertriglyceridaemia, in 
which they also found that hyperlipidaemic patients had significantly lower 
fibrinolytic activity (Simpson et aI., 1983). 
When comparing two groups of Africans it was found that the group who had a 
higher fat and fiber intake as well as a lower cholesterol intake, had a higher 
fibrinogen level than the group with a lower fat intake (Vorster et al. , 1997). 
Results from the THUSA study in South Africa showed that a small, but 
Significant, positive correlation exists between serum cholesterol, LDL 
cholesterol and triglycerides (in women) with elevated plasma fibrinogen 
(James et aI., 2000). 
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2.5.3 Diabetes mellitus 
The plasma fibrinogen levels are frequently elevated in diabetes mellitus and 
particularly in patients with vascular complications and impaired metabolic 
control (Ganda et aI., 1992). Altered properties of fibrin gel structure in 
patients with insulin dependant diabetes mellitus (100M) have also been 
demonstrated despite normal fibrinogen levels (Jorneskog et al., 1996 and 
Nair et aI., 1991b). 
2.5.4 Age 
The Framingham Study showed a diminishing impact of CHO with advancing 
age only in women. It was also found that the risk of CHO increased 
progressively with fibrinogen levels in both sexes below the age of 60 years 
(Kannel et al., 1987). Many other studies have also reported that fibrinogen 
levels increase with age (Armani et aI., 1992 & Avellone et aI., 1991). 
2.5.5 Hypertension 
Five decades of epidemiologic research have established that blood pressure 
elevation is a common and powerful contributor to all of the major 
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cardiovascular diseases, including coronary disease and stroke. Studies on 
the risk stratification in hypertension as part of new insights on the 
Framingham Study, showed elevated heart rate, left ventricular hypertrophy 
and an elevated fibrinogen concentration as factors that often accompany 
hypertension (Kannel , 2000). A statistically significant difference between 
fibrinogen levels was also found in a study performed on a control group of 
healthy women and pregnant women with severe chronic hypertension 
(Kendi et aI., 2000). 
2.5.6 Obesity & body mass index 
A study performed on obese women in South Africa who took part in a weight 
reduction program over eight weeks showed large fluctuations in plasma 
fibrinogen, which increased during the phases of substantial weight loss. 
The trend however, was for fibrinogen concentration to decrease over the 
eight weeks with a mean weight loss of 9.2 ± 2.9 kg (Vorster et aI., 1989). It 
was also found that the lifetime health and economic consequences of 
obesity are substantial and suggested that efforts to prevent or reduce this 
problem might yield significant benefits (Thompson et aI., 1999). 
In obese patients (8M I > 30kg/m2) the plasma viscosity and plasma fibrinogen 
levels are significantly increased compared to healthy (8MI < 25kg/m2) 
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subjects (Lip 1995). In the THUSA study done on Africans in South Africa 
BMI showed a significant positive correlation with plasma fibrinogen levels 
(James et aI., 2000). Folsom et al (1991) developed two models to predict 
changes in fibrinogen for a 5 kg/m2 increase in BMI. The influence of BMI on 
plasma fibrinogen level was greater in women than in men, with the first 
model showing a 1.23g/L increase and the second showing a 0.98g/L 
increase. 
2.5.7 Smoking 
Several studies concluded that elevated fibrinogen levels probably explained a 
considerable part of the causal association between smoking and 
cardiovascular disease (Meade et aI., 1987 & Kannel et aI., 1987). An 
association between smoking and fibrinogen levels was also described by 
MlIlller & Kristensen (1991). 
2.5.8 Oral contraceptives & hormone replacement therapy 
Women tend to have higher fibrinogen levels than men, especially after the 
menopause or with the use of oral contraceptive drugs. It seems that oral 
contraceptives with high oestrogen content have the strongest effect. 
Fibrinogen returns to normal within three months upon discontinuation of the 
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drugs (Ernst, 1991). In contrast to this, it was concluded that hormone 
replacement treatment with 17 beta-oestradiol for nine weeks significantly 
increased fibrinolytic potential in postmenopausal women with mild 
dyslipidaemia. This suggests that oestrogen may also have a 
cardioprotective effect that might be mediated in part by an increase in 
fibrinolytic potential (Gebara et aI., 1998). In the CARDIA study the use of 
oral contraceptives by women was associated with higher fibrinogen levels 
(Folsom et al., 1993). However, the opposite was found to be true for the 
SHHS study (Lip 1995). Pregnancy is also often associated with a rise in 
plasma fibrin levels, but this is also accompanied by a compensatory rise in 
fibrinolytic potential (Yin et aI., 1998). 
2.5.9 PhYSical activity 
Fibrinogen levels increase with age. In a study performed on young (24-30 
years) and old (60-82 years) men who followed an intensive six month 
endurance exercise program, a reduction in fibrinogen levels by 13% was 
demonstrated in the older group (Stratton et aI., 1991). A significant 
univariat and multivariat association between physical inactivity and 
fibrinogen levels was also described by Mlillier & Kristensen, in 1991 . This 
association was also confirmed by Haddock et al. in 1998, when they 
concluded that cardiorespiratory fitness was an important independent 
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determinant of blood lipid and fibrinogen levels in non-smoking 
postmenopausal women, independent of the use of hormone replacement 
therapy. Therefore it seems that all studies which measured the relationship 
between long-term physical activity and plasma fibrinogen, found that 
physical fitness is associated with lower levels of the protein in blood. 
However, less is known about the acute effect of physical activity on plasma 
fibrinogen levels. 
2.5.10 Psychological stress and social class 
In a study performed on Danish men, it was found that fibrinogen levels were 
higher in men from low social class and among men living alone (M0l1er & 
Kristensen, 1991). Brunner concluded that socially patterned accumulation 
of health capital and cardiovascular risk begins in childhood and continues, 
according to socio-economic position, during adulthood. In this study, adult 
occupational position was inversely associated with fibrinogen, other 
metabolic risk factors and other risk factors such as smoking and leisure time 
physical inactivity. Childhood social position was associated with adult 
weight in both sexes and with current smoking and fibrinogen concentrations 
in women (Brunner et aI., 1999). The cause of higher plasma fibrinogen 
levels in lower socio-economic classes is not clear. It could be related to 
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environmental factors such as nutrition, smoking, alcohol and drug abuse 
and also the prevalence of chronic lower grade infections. 
2.5.11 Ethnicity 
There seems to be a co-existing variation between plasma fibrinogen levels and 
the prevalence of ischaemic heart disease across populations. It is known 
that fibrinogen levels are lowest among Asians, intermediate among English, 
Gzechs and North American whites, and highest among Finns, Scots, 
African Americans, Gambians and some American Indian tribes (Folsom 
1995). In the Bogalusa Heart Study plasma fibrinogen levels did not differ 
essentially between Blacks and Caucasians or males and females, although 
an increase in levels with age or sexual maturation was noted in black 
females (Bao et aI., 1993). The fact that plasma fibrinogen levels are higher 
in post menopausal women and thus older women, is a well know fact, but in 
this case the authors also suggested a higher level in black females. 
Table 2.1 Sex, race and age-specific mean plasma fibrinogen levels (mg/dL) 
d t f rt" t 'thfib ' I 1350 IdL an percen age 0 pa IClpan s WI I nnogen eve s > mgi 
Age Men Women 
Whites (n - 1.042) Blacks (n=891) Whites (n=1 .123) Blacks (n=1.137) 
Mean SO %>350 Mean SO %>350 Mean SO %>350 Mean SO %>350 
<30 23B 44 2 246 48 4 263 52 5 287 59 13 
>30 244 50 3 254 49 3 267 5B B 295 63 14 
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Table 2.1 shows data collected from the CARDIA study from 1990-1991 . This 
data shows that the mean fibrinogen levels were higher in the older age group, 
in women rather than in men and in blacks rather than in whites (Folsom et aI., 
1993). 
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CHAPTER 3 
METHODS 
3.1 Study design and workplan 
This study used a randomized comparative design which formed part of a larger 
study (Nutritional Health of Women Stydy) performed by Dr C Walsh. All 
laboratory measurements and procedures were performed within the 
Research Laboratory of the Fibrinogen Unit, School of Health Technology, 
Technikon Free State, as well as the Laboratory of Drs Voigt, Ie Roux and 
Partners, Bloemfontein. 
The contribution of the researcher included the following : 
• The design and implementation of the questionnaire (Appendix B) 
• Assistance in the obtaining of blood samples 
• All laboratory investigations 
For the purpose of this study the level of socio-economic status were linked to 
"urbanization", which were defined by the percentage lifetime spent living in an 
urban area and the years spent living in an urban area. 
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3.2 Ethical approval 
Ethics Committee approval for the Nutritional Health of Women Study (Dr C. 
Walsh, Technikon Free State) was obtained from the University of the 
Free State (Etovs no. 02/00). Ethics Committee approval was also 
obtained for this particular study from the University of the Free State 
(Etovs no. 45/00). 
3.3 Subjects 
3 groups of volunteers from different socio-economic backgrounds were 
randomly chosen to participate in this study. The white women were ali 
employees of the Technikon Free State and the black women came from the 
black suburbs in and around Bloemfontein. 
• 30 "less urbanized" black women from the Free State area. This group was 
obtained from the Nutritional Health of Women Study performed by Dr C 
Walsh, School of Tourism, Hospitality and Sport, Faculty of Management, 
Technikon Free State. "Less urbanized" was defined as those subjects living 
in an urbanized setting for less than thirty years. 
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• 30 "urbanized" black women from the Nutritional Health of Women Study 
performed by Dr C Walsh, School for Tourism, Hospitality and Sport, Faculty 
of Management, Technikon Free State. "Urbanized" was defined as those 
subjects living in an urbanized setting for longer than thirty years . 
• 27 urbanized white women obtained from the personnel corps of the 
Technikon Free State (TFS). The group consisted of only 27 subjects 
because all the subjects were volunteers from the TFS. 
3.4 Inclusion/exclusion criteria 
The inclusion criteria for the subjects were as follows: 
• Women, aged 35-44. 
• No history of any cardiovascular events, chronic disease states, familial 
abnormalities or any other physical abnormalities. 
• Subjects should be non-smokers. 
• Subjects should not be alcohol dependent. Liver enzymes were determined 
for confirmation (GGT assays). 
• No medication (including oral contraceptives) may be used during the project, 
unless prescribed by a general practitioner. 
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• Subjects should not be glucose intolerant (fasting glucose levels < 6.0 
mmollL) 
• Subjects should be HIV negative. 
• Subjects should all be pre-menopausal and within day 21 - 30 of their 
menstrual cycle. 
3.5 Laboratory procedures 
Fasting blood samples were taken by a registered nurse from all subjects. Fibrin 
network architecture variables, serum glucose, hormone profiles (female sex 
honmones), HIV status and some other metabolic risk markers were 
measured on fresh blood samples using the described techniques. 
3.5.1 Sample preparation 
3.5.1.1 Plasma 
For the preparation of essentially platelet-free plasma, 10 mL citrated blood (1 
volume of 3.8 % tri-sodium citrate [Saarchem, South Africa, Cat. no. 582 
25 00] in a 0.1 M sodium phosphate buffer, pH 7.4, with 35 ~L of 10.000 
KIU/mL Trasylol®/aprotinin per 9 volumes of whole blood) was centrifuged 
twice, for 10 minutes at 8000 g. Citrate acts as an inhibitor of early 
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activation of factor V and VIII. Aprotinin (Trasylol®, Bayer-Miles, Germany, 
Cat. no. H2912) acts as an inhibitor offibrino(geno)lysis. 
Determinations involving fibrin network structure properties were performed 
on fresh plasma samples . All remaining plasma was stored at -72 °C in 
Eppendorf vials. 
3.5.1 .2 Serum 
5 mL of whole blood was left to clot at room temperature. These samples 
were centrifuged at 3660 rpm for 10 minutes in order for the serum to 
separate. Samples were frozen and stored at -72 °C in Eppendorf vials. 
3.5.2 Measurement of biochemical variables 
3.5.2.1 Compaction of fibrin networks 
Compaction was measured in duplicate using the method described by Dhall 
et al. (1976). The compaction technique describes the tensile strength of 
fibrin fibers. The inverse correlation between compaction and Young's 
modulus, and between compaction and strength at break, indicates that 
the simple method of compaction depends on the number and strength of 
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the primary crosslinks and branch pOints in the network (Nair et al., 
1991a). 0.9 mL fresh plasma was pipetted into 1.5 mL Eppendorf'l vials, 
pre-sprayed with lecithin-based aerosol (Spray-&-Cook)® to render the 
surface non-adhering. The plasma was clotted by introduction of 100 IJL 
Thrombin Reagent (ICN, USA, Cat. no. 101141); 1 IU/mL Thrombin final 
concentration, 25 mM Ca2+ final concentration). Samples were left 
overnight for maximum polymerisation. After centrifugation at 8000 g for 
45 seconds the volume of expelled sample from the fibrin networks was 
determined, and expressed as a percentage of the initial volume. The 
C. V. for this method was 2.3%. 
3.5.2.2 Mass length ratio from turbidity (J.IT) 
Mass length ratio from turbidity (IJT) was determined (n=2 for each sample) 
using the method as described by Nair et al. (1991a). 0.9 mL of fresh 
platelet-free plasma was pi petted into micro-cuvettes of 1 cm path length. 
The plasma was mixed and clotted by introduction of 100 IJL Thrombin 
Reagent (ICN, USA, Cat no. 101141); 1 IU/mL Thrombin final 
concentration, 25 mM Ca2+ final concentration). 
The intercept, A. in plots of c/T(wavelength)3 as a function of 1/(wavelength)2 
was used to calculate IJT (mass length ratio) according to the equation : 
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fJT = [10/1.48xA) x 1012 daltons/cm 
Turbidity (optical density) was measured at a range of wavelengths between 
600 and 800 nm (Shimadzu, UV-1201 , Japan). The CY for this method 
was 5%. 
3.5.2.3 Network lysis rate 
The network lysis rate was measured in duplicate using a method developed 
in our own laboratory. 90 fJl of plasma was mixed and clotted by the 
introduction of 10 fJl Thrombin reagent (ICN, USA, Cat no. 101141; 1 IU/ml 
Thrombin final concentration, 25 mM calcium final concentration) in 
microtiter plates. After total polymerisation took place 50 fJL of 
Streptokinase (ICN, USA, Cat no. 101114) with a final concentration of 
100 U/ml was introduced to start lysis of networks. The lysis rate was 
measured with an EL 312e from Biotek instruments at 608 nm for 6 hours 
using 10 minute intervals. The lysis rate was determined by plotting the 
time versus change in absorbance. The C. V. for this method was 4.2%. 
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3.5.2.4 Total plasma fibrinogen concentration and network 
fibrin content 
The method of Ratnoff & Menzies (1951) was used for duplicate determination 
of the fibrin content of fibrin networks for all fibrin network structure 
determinations. 
The Ratnoff & Menzies method : 0.9 mL plasma for network fibrin content in 
test tubes filled with 1 g glass beads (Saarchem, South Africa, cat. no. 
267 02 50) was clotted under identical conditions as described for 
mass length ratio determinations. Samples were left overnight for total 
polymerisation to take place. All samples were centrifuged at 1300 x g. 
The isolated networks were washed three times with saline solution. 1 
mL 2.5 M NaOH (Saarchem, South Africa, cat. no. 582 31 80) was 
dispensed into each test tube, the networks dissolved by heating at 
95°C for 15 minutes. The samples were left to cool at room 
temperature. 7 mL water and 3 mL 1.9 M sodium carbonate 
(Saarchem, South Africa, cat. no. 582 20 40) was dispensed into each 
tube, containing 200 !JL of the NaOH-fibrin suspension. The tubes 
were vortexed and mixed with 1.0 mL Folin & Ciocalteu's Reagent 
(Saarchem, South Africa, cat. no. 243 300) . Samples were incubated 
at room temperature for 20 minutes and absorbances measured at 650 
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nm. Different concentrations of DL-Tyrosine (Sigma, U.S.A, SI. Louis, 
cat. no. T-3379) dissolved in 25 M NaOH was used to prepare a 
standard curve. This curve was used to calculate the concentration of 
fibrin present in unknown samples. The C.v. for this method was 
0.04%. 
3.5.2.5 Female sex hormones 
Female steroid hormones were measured using the Bayer ADVIA® Centaur™ 
System. For Luteinizing Hormone (LH) (Bayer Diagnostic, USA, cat no 
110754) and Follicle Stimulating Hormone (FSH) (Bayer Diagnostic, USA, 
cat. no. 110756) the assay is a two-site sandwich immunoassay using 
direct chemiluminometric technology, and for Progesterone (Prog) (Bayer 
Diagnostic, USA, cat. no. 1199592) and estradiol (E2) (Bayer Diagnostic, 
USA, cat. no. 110785) the assay is a competitive immunoassay using 
direct chemiluminescent technology. 
3.5.2.6 Other metabolic risk markers 
The haemostatic risk factor, fibrinogen concentration was determined using 
the Behring Coagulation Timer using Multifibren® U (Dade Behring, 
Marburg GmbH, Germany. Cat. no. OWZG 15). Fibrinogen-Standards 1-
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4 (Dade Behring, Marburg GmbH, Germany. Cat. no. OWCS 11) was 
used to draw a calibration curve for fibrinogen concentration 
determination. Control Plasma N (Dade Behring, Marburg GmbH, 
Germany. Cat. no. ORKE 35) was used as a control for normal fibrinogen 
concentrations and Control Plasma P (Dade Behring, Marburg GmbH, 
Germany. Cat. no. OUPZ 13) was used as a control for pathological 
fibrinogen concentrations. 
Other metabolic variables (Table 1) were determined using a Boehringer 
Mannheim/Hitachi 902 Automated Chemistry Analyser (Hitachi Ltd Japan). 
Table 3.1 Methods used for the determination of different biochemical 
variables 
Variable Supplier & Cat. no. Principle 
Total protein Roche Diagnostics GmbH, Colorimetric 
(TP) Mannheim, Germany. 
# 1553836 
Albumin (ALB) Roche Diagnostics GmbH, Colorimetric 
Mannheim, Germany. 
# 1970569 
Total cholesterol Roche Diagnostics GmbH, Enzymatic colorimetric 
(TC) Mannheim, Germany. 
# 1489232 
Glucose (GLC) Roche Diagnostics GmbH, Enzymatic colorimetric 
Mannheim, Germany. 
# 1448668 
Triglycerides Roche Diagnostics GmbH, Enzymatic colorimetric 
(TG) Mannheim, Germany. 
# 1488872 
* S.F.A.C. (Cat no. 759350, Roche Diagnostics GmbH, Mannheim, Germany.) 
was used as calibrator for chemistry measurements. 
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Precinorm® U (Roche Diagnostics GmbH, Mannheim, Germany. Cat. no. 
171735) was used as a control for normal chemistry values and Precipath® 
U (Roche Diagnostics GmbH, Mannheim, Germany. Cat. no. 171760) as 
control for pathological range values. 
3.5.2.7 Full blood counts and HIV status 
Full blood counts were performed on EDTA blood using a Coulter Microdiff 18 
Cell Counter. HIV tests were performed on an Abbott AxSYM ® System, 
using the Human Immunodeficiency Viruses (HIV-1/HIV-2): (Recombinant 
Antigens and Synthetic Peptides) reagent pack (Abbott, Germany, cat. no. 
3D41-20). The HIV 1/2 gO reagent pack is for the in vitro qualitative 
detection of antibodies to human immunodeficiency virus type one and/or 
type two in human serum or plasma, by Microparticle Enzyme 
Immunoassay. 
3.6 Other information 
This project formed part of a bigger project. Other researchers also obtained 
information for their own purpose. However, for this study the following 
information was obtained: 
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• Questionnaires were completed to obtain pre-menopausal data, personal 
information and information on socio-economic status. 
• A general medical examination was performed by a general practitioner to 
eliminate any gross pathology. 
• Each subject signed a form of consent. 
3.7 Statistical analysis 
Percentage lifetime was described by medians and percentiles for each group. 
The median difference between the groups was compared by the non-
parametric KruskaJl-WaJlis test and 95% confidence intervals for the median 
difference. 
The number of respondents in each group was described by means of 
frequencies and percentages. For each group, the continuous variables 
were described by means and standard deviations in case of normally 
distributed data. Medians, and percentiles were used to describe skewly 
distributed variables. 
Within each group, Spearman correlation coefficients were calculated between 
the different variables. 
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The differences in the values of clotting factors between the three subject groups 
were calculated by means of the Kruskall-Wallis test or the one-way analysis 
of variance. as applicable. Statistical differences found between the three 
groups for normally distributed variables were compared by the Scheffe-test 
between each pair. This was done in order to identify which pair of variables 
influences the overall statistical significance most. 
Confidence intervals for the mean difference were also calculated. The intervals 
were clinically interpreted for significance. 
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CHAPTER 4 
RESULTS 
In this Chapter, the results of the study are given in table form with emphasis on 
the significant differences. 
4.1 Socio-economic status of the three different subject groups 
Table 4.1 shows frequencies and percentages for the level of education and 
employment status of the three different groups of subjects. 
There was no significant difference between the level of education of the less 
urbanized and urbanized black groups, with more than 80% of the subjects in 
both these groups having an educational level lower than or equal to Grade 
10. All of white women had an educational level of higher than Grade 10. 
As with level of education, the employment status of the two black groups 
showed very little difference. In the less urbanized group 22 (73.3%) were 
unemployed and 8 (26.7%) employed, and in the urbanized group 21 (70%) 
were unemployed and 9 (30%) employed. All of the women in the white 
group were employed. 
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Table 4.1 Socio-economic status (level of education and employment status) of the 
three groups of women 
Parameters Less urbanized black Urbanized black White 
(n=30) (n=30) (n=27) 
Level of education 
None - Grade 10 25(83.33%) 26(86.67%) 0(0%) 
> Grade 10 5(16.67%) 4(13.33%) 27(100%) 
Employment status 
Unemployed 22(73.33%) 21(70.00%) 0(0%) 
Employed 8(26.67%) 9(30.00%) 27(100%) 
Table 4.2 shows the median, median difference, confidence intervals and p-
values of the level of "urbanization" (years living in an urban area, and 
percentage lifetime spent in an urban area) for the three different subject 
groups. 
There was no significant difference between the median age of the three 
different subject groups, with all the groups having a median age of about 41 
years. There was a significant difference between the years spent living in 
an urban area (Table 4.2) for the three groups, and thus also the percentage 
lifetime spent in an urban area (Table 4.3). The median years spent living in 
an urban area was 10.5 years for the less urbanized black group, 39.5 years 
for the urbanized black group and 23 years for the white group. The 
percentage lifetime spent in an urban area also differed significantly between 
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the three groups. The median percentage lifetime spent in an urban area 
was 26.08% for the less urbanized black group, 99.32% for the urbanized 
black women and 52.09% for the white women. 
Table 4.2 Age , years spent living in an urban area and percentage lifetime spent in an 
urban area of the three groups. 
Group Median Kruskall-Wallis 
p-values 
Age LUB 40.68 
UB 40.93 0.5797 
White 41.12 
'Years LUB 10.5 
spent living 
in an urban US 39.5 <0.0001 
area 
White 23.0 
'Percentage LUB 26.08% 
lifetime 
spent in an US 99.32% <0.0001 
urban area 
WhIte 52.09% 
LUB=less urbanized black, US-urbanized black. 
Means significant differences between the groups for the same variable. 
Table 4.3 The differences in percentage lifetime spent in an urban area . 
Group Median difference 95% Confidence 
interval for median 
difference 
UB-LUB 71 .1 2% [63.74% - 75.10%] 
White - LUB 72.86% [7.69% - 56.67%] 
US - White 39.76% [1.05% - 63.14%] 
LUS-Iess urbanized black, US-urbanized black. 
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Table 4.3 shows the differences in percentage lifetime spent in an urban area by 
means of the median differences and non-parametric 95% confidence interval 
for median differences using the method as described by Altman et ai, 2001. 
Significant differences were obvious between the urbanized black and less 
urbanized black women, as well as between the white and less urbanized black 
group. 
4.2 Descriptive data of the metabolic variables for the three 
different subject groups 
Table 4.4 shows the mean, SO, 01, 03, skewness and normal ranges of each of 
the metabolic variables for the three different groups of subjects. The mean 
8MI of the white women was only slightly higher than that of the less 
urbanized and urbanized black women, but the values of all three the groups 
are slightly above normal, and can be classified as being overweight (25-30 
kg/m\ but not obese (>30kg/m\ However, this has no influence on the 
results of this study due to the fact that all three subject groups fell within the 
same weight category. Serum glucose, albumin, total cholesterol and 
triglycerides did not show any Significant difference between .the three groups 
or from the normal ranges. The mean total protein of the white women was 
significantly lower than that of both the urbanized and less urbanized black 
women, the mean of the two black groups being about 70% higher than that 
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of the white women. The values of both the urbanized and less urbanized 
black women were also above the normal reference ranges for serum total 
protein. This is a common occurrence in the clinical laboratory, however of 
no clinical significance. 
Serum LH of the white women was lower than that of both the black groups. The 
mean values of all three these groups, however, fell within the normal 
ranges for day 21 - 30 of the menstrual cycle. FSH values of the white 
group also differed from the values of the two black groups, but in this case 
the mean values of the black groups were above the normal range, while the 
mean levels of the white women were within the normal ranges for day 21 -
30 of the menstrual cycle. The mean estradiol values of the urbanized black 
women were the lowest of the three groups. The mean values of the less 
urbanized black women, in contrast, were the highest of the three groups, 
with a 45% difference between the mean values of the less urbanized and 
urbanized black groups. This difference, however, was not significant. It is 
noted that the means of both these groups fell within the normal ranges for 
day 21 - 30 of the menstrual cycle. The mean progesterone levels of the 
white women were higher than that of the two black groups. The difference 
between the mean progesterone levels of the white group arid the two black 
groups is not significant. However, the mean progesterone levels of the two 
black groups fell below the normal reference range given for day 21-30 of 
the menstrual cycle. 
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Table 4.4 Physical and metabolic variables of all th ree groups of women from d ifferent 
socio-economic backgrounds 
Physical & metabolic Group X SO Q3 Skew Ql Normal 
variables Ranges 
Body Mass LUB 26.7 4.9 28.7 26.6 23.5 18.5 - 25 
Index/BMI (kglm2) UB 26.6 5.6 30.0 25.4 22.6 18.5 - 25 
White 28.2 8.0 33.1 25.2 22.8 18.5- 25 
Estradiol1E2 (pmoVL) LUB 502.3 825.5 559.0 260.0 73.4 121 - 551 
UB 346.4 226.8 535.0 289.5 146.0 121 551 
White 454.2 545.0 511.0 291.0 130.0 121 -551 
Luteinizing LUB 11.2 12.0 14.8 5.5 3.8 0.5 -17 
HormonelLH (IU/L) UB 11.4 11.9 19.4 6.0 3.2 0.5 - 17 
White 5.17 7.5 5.4 3.5 2.3 0.5-17 
Follicle Stimulating LUB 17.7 20.4 18.4 7.7 5.4 1-9 
HormonelFSH (IU/L) UB 13.5 15.6 15.8 8.7 5.5 1-9 
White 5.8 3.3 7.8 5.5 3.5 1-9 
Progesterone/Prog LUB 9.2 19.2 2.2 0.8 0.5 10 - 89 
(nmoIlL) UB 9.8 21.7 3.2 0.9 0.6 10 - 89 
White 14.4 22.4 21.1 0.9 0.7 10 - 89 
GlucoselGLC LUB 4.6 0.97 4.9 4.5 4.1 3.6-5.6 
(mmol/L) UB 4.6 0.91 5.4 4.5 42 3.6-5.6 
White 4.2 0.93 4.7 4.4 4.1 3.6-5.6 
Albumin/ALB (giL) LUB 43.1 3.1 44.7 43.0 41.6 35- 52 
UB 43.2 3.0 44.2 42.7 41 .4 35-52 
White 42.9 2.0 442 42.8 41.7 35-52 
Total ProteinfTP LUB 83.5 5.8 86.5 83.5 80.0 60- 82 
(giL) UB 84.9 6.4 89.0 84.5 80.0 60-82 
White 75.3 3.0 77.0 76.0 72.0 60 - 82 
Total CholesterolfTC LUB 5.3 1.1 6.1 5.1 4.3 4.1 -6.2 
(mmol/L) UB 4.9 1.3 5.5 4.8 42 4.1 - 6.2 
White 5.5 0.9 6.3 5.1 4.8 4.1 -6.2 
TriglyceridesfTG LUB 1.5 0.8 1.9 1.4 0.9 0.40-2.26 
(mmoI/L) UB 1.5 1.7 1.4 1.0 0.8 0.40 - 2.26 
White 1.3 0.5 1.7 1.3 0.9 0.40 - 2.26 
No significant differences between metabolic vanables were found between any 
groups. 
LUB=less urbanized black, UB=urban black. 
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4.3 Descriptive data of the haematological variables for the three 
different subject groups 
Table 4.5 shows the mean, SO, Q1 , Q3, skewness and normal ranges of each of 
the haematological variables for the three different groups of subjects. 
Table 4.5 Haematological variables for all three groups of women from different socio-
economic background 
Haematological Group X SO 03 Skew 01 Normal 
variables Ranoes 
Red Blood lUB 4.42 0.39 4.64 4.42 4.17 4.2 -5.2 
Cells/RBC (10'S/lll) 
UB 4.41 0.34 4.54 4.39 4.19 4.2- 5.2 
White 4.65 0.32 4.78 4.65 4.46 4.2-5.2 
HemoglobinlHb lUB 13.91 0.98 14.60 13.80 13.30 11.5 - 16.5 
(gldl) 
UB 13.80 1.20 14.40 13.90 13.00 11.5-16.5 
White 14.10 0.80 14.70 14.10 13.30 11 .5-16.5 
Fibrinogen/Fb (gil) LUB 3.49 1.00 3.86 3.27 2.92 1.5 - 4.0 
UB 4.03 1.16 4.96 4.12 3.09 1.5-4.0 
White 3.76 1.11 4.71 3.38 2.96 1.5-4.0 
Compaction of fibrin lUB 46.50 10.00 51.0 45.00 40.00 NE 
networks'/CFN (%) 
UB 48.40 15.00 59.0 49.00 37.00 NE 
White 48.00 10.00 52.0 47.00 40.00 NE 
Mass length lUB 58.70 15.60 69.7 60.20 49.20 NE 
ratio'/IlT (Oa/cm x 
10A12) UB 59.70 19.90 70.1 57.20 49.70 NE 
White 62.10 20.60 76.2 62.1 46.70 NE 
Network fibrin lUB 0.13 0.04 0.1 3 0.12 0.11 NE 
content*/NFC (gil) 
UB 0.13 0.03 0.15 0.13 0.11 NE 
White 0.14 0.04 0.16 0.12 0.11 NE 
.. No Significant differences between haematologlcal vanables were found between any 
groups. 
'=developed at a final concentration of 1 IU/mL thrombin and a final concentration of 
25 mmol Ca2+. LUB=less urbanized black, UB=urban black, NE=not established. 
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RBC and Hb mean values were within the normal reference ranges for all three 
the subject groups. This was expected, as all the subjects were HIV 
negative, were non-smokers and did not have any gross clinical 
abnormalities as specified in the strict inclusion criteria adhered to during 
recruitment of the volunteers. No significant differences between the mean 
plasma fibrinogen values of the urban black and white women (14% of the 
mean), less urbanized and urban black women (13% of the mean) and less 
urbanized black and white women (8% of the mean) were recorded. 
However, in contrast to the mean fibrinogen values of the white and less 
urbanized black women, the mean fibrinogen value of the urban black 
women fell just above the upper international cut-off value of 4 giL for 
plasma fibrinogen. It is believed that this small elevation may be of no 
clinical significance within the black population group of South Africa, and 
will be discussed in the next Chapter. The mean values of the fibrin network 
compaction which is used as an index of the tensile strength of fibrin fibers 
within the fibrin networks were basically the same for the white and 
urbanized black women, while the mean values of the less urbanized black 
women were only Slightly lower. The difference was also non-significant. 
The mean values for the mass length ratio of the fibrin fibers (an index used 
to describe the relationship of the ratio between the length and thickness of 
the fibrin fibers within the network structure) within the networks showed no 
significant difference between the less urbanized and urbanized black 
groups, as well as between the urbanized black and white groups, with only 
CE"liIip.LOU~~~~~fs~:iE 
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a 5% difference between the values of the less urbanized black and white 
groups. No difference was recorded between the mean values of the 
network fibrin content of the three groups. 
0.74 
0.72 
GI 0.7 
u 
c 
III 
~ 0.68 
1/1 
.c 
ca: 0.66 
0.64 
0.62 
-p 
, 
o 
30 
k . 
1/ , 
-, , 
, , 
60 120 180 240 300 
90 150 210 270 330 
Time/minutes 
UB LUB 
-- --
-----.... 
-
, , 
, 
360 420 
390 450 
White 
Figure 4.1 Lysis rates of fibrin networks for three different groups of socio-economic 
status. Developed at a final concentration of 1 lU/mL thrombin and a final 
concentration of 25 mmol Ca2+. 
The lysis rate of fibrin networks formed from human plasma explains the 
property of the fibrin networks to be broken down by the fibrinolytic enzymes 
present in blood. Under experimental conditions a standard lytic potential is 
developed by adding a fixed amount of excess streptokinase, an enzyme 
with fibrinolytic potential. These conditions urge the lysis potential to be 
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solely dependent on the structurelfunction characteristics of the fibrin 
strands within the network, including the concentration of the fibrin protein 
deposited within the fibrin network. During normal physiological functioning 
the rate would also depend on the concentrations of the different lytic 
enzymes, which may also vary from individual to individual. Consequently, 
during network studies a standard lytic potential for measuring network lysis 
rate is created. 
As fibrin fibre size is decreased, the fibrinolytic rate also decreases. Thin fibrin 
fibres have a decreased rate of conversion of plasminogen to plasmin by 
tPA and thin fibres are lysed more slowly than thick fibrin fibres (Gabriel et 
aI., 1992). This phenomenon was explained by experiments which have 
shown that the number of tPA binding sites and fibrinolytic rate (Gabriel et 
aI., 1991) are dependent on fibrin structure. Since structural features at the 
end of fibrin assembly may determine the potential number of binding sites 
for the fibrinolytic enzymes, it is probable that thin fibres posess fewer 
plasmin binding sites, possibly as a function of the decreased surface of the 
thin fibres (Gabriel et al., 1992). This may be due to (i) a decrease in the 
number of binding sites resulting from the smaller surface area of thin fibres 
or (ii) steric factors caused by the curvature of the thin fibres which prohibit 
stable interaction between tPA and its binding site (Gabriel et al., 1992). 
Fibrin, with its ordered structure, appears to exert its rate-enhancing effect 
by presenting its binding sites for interaction with tPA and plasminogen, thus 
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concentrating and correctly orienting these two reactants on its surface and 
inducing conformational changes which lead to higher catalytic efficiencies 
(Nieuwenhuizen, 1994). 
Figure 4.1 shows the lysis rates for the three different subject groups. It is 
evident from this graph that the lysis rate of fibrin networks of the group of 
less urbanized black women (red line) was the highest, and that the lysis 
rate of the fibrin networks of the group of white women (yellow line) was the 
lowest. The lysis rate of the fibrin networks for the group of urbanized black 
women (blue line) fell between the white and less urbanized black women 
groups. 
4.4 Correlations between baseline variables 
Tables six to nine show Spearman's correlation coefficients between the 
metabolic variables within each of the three different subject groups, as well 
as the correlation coefficients between the metabolic variables within the 
subject group as a whole. 
In Table 4.6 Spearman's correlation coefficients of the variables that correlated 
with one another are given for the group in total. Positive correlations were 
found between serum LH and FSH, ALB and TP, RBC and Hb, as well as 
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between plasma fibrinogen and NFC. There was a negative correlation 
between ~T and NFC. 
In Table 4.7 Spearman's correlation coefficients of the variables that correlated 
with one another in the group of less urbanized black women are given. The 
following positive correlations occurred: between E2 and both ALB and TP, 
between serum LH and FSH, ALB and both TP and Hb, between plasma 
fibrinogen and NFC and between CFN and ~T . There was a negative 
correlation between ~T and NFC. 
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Table 4.6 Spearman's correlation coefficients between variables of the group as total 
E2 LH FSH Prog GLC ALB TP TC TG RBC 
E2 1 
LH NS 1 
FSH NS 0.74 1 
Prog NS NS NS 1 
GLC NS NS NS NS 1 
ALB NS NS NS NS NS 1 
TP NS NS NS NS NS 0.50 1 
TC NS NS NS NS NS NS NS 1 
TG NS NS NS NS NS NS NS NS 1 
RBC NS NS NS NS NS NS NS NS NS 1 
Hb NS NS NS NS NS NS NS NS NS 0.53 
Fb NS NS NS NS NS NS NS NS NS NS 
CFN NS NS NS NS NS NS NS NS NS NS 
IJT NS NS NS NS NS NS NS NS NS NS 
NFC NS NS NS NS NS NS NS NS NS NS 
BMI 
NS : Non-significant; Significant (p>0.5) 
Hb Fb CFN IJT NFC BMI 
1 
NS 1 
NS NS 1 
NS NS NS 1 
NS 0.70 NS -0.72 1 
© Central University of Technology, Free State
Table 4.7 Spearman's correlation coefficients between variables of the less urbanized black women 
E2 LH FSH Prog GLC ALB TP TC TG RBC Hb Fb CFN ~T NFC BMI 
E2 1 
LH NS 1 
FSH NS 0.85 1 
Prog NS NS NS 1 
GLC NS NS NS NS 1 
ALB 0.50 NS NS NS NS 1 
,-" TP 0.57 NS NS NS NS 0.59 1 
TC NS NS NS NS NS NS NS 1 
TG NS NS NS NS NS NS NS NS 1 
RBC NS NS NS NS NS NS NS NS NS 1 
Hb NS NS 0.60 NS NS 0.55 NS NS NS NS 1 
Fb NS NS NS NS NS NS NS NS NS NS NS 1 
CFN NS NS NS NS NS NS NS NS NS NS NS NS 1 
liT NS NS NS NS NS NS NS NS NS NS NS NS 0.52 1 
NFC NS NS NS NS NS NS NS NS NS NS NS 0.71 NS -0.69 1 
BMI 
NS ; Non-significant; Significant (p>0.5) 
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Table 4.8 Spearman's correlation coefficients between variables within the urbanized black women 
E2 LH FSH Prog GLC ALB TP TC TG RBC Hb Fb 
E2 1 
LH NS 1 
FSH NS 0.74 1 
Prog NS NS NS 1 
GLC NS NS NS NS 1 
ALB NS NS NS NS NS 1 
TP NS NS NS NS NS 0.59 1 
TC NS NS NS NS NS NS NS 1 
TG NS NS NS NS NS 0.51 NS NS 1 
RBC NS NS NS NS NS NS NS NS NS 1 
Hb NS NS NS NS NS NS NS NS NS 0.54 1 
Fb NS NS NS NS NS NS NS NS -0.54 NS NS 1 
CFN NS -0.62 NS NS NS NS NS NS NS NS NS NS 
liT NS NS NS NS NS NS NS -0 .53 NS NS NS NS 
NFC NS NS NS NS NS NS NS NS NS 0.51 NS 0.77 
8MI 
NS : Non-significant; Significant (p>O.5) 
CFN liT NFC BMI 
1 
NS 1 
NS -0.68 1 
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Table 4.9 Spearman's correlation coefficients between variables in the white group 
E2 LH FSH Prog GLC ALB TP TC TG RBC 
E2 1 
LH NS 1 
FSH NS 0.78 1 
Prog NS NS NS 1 
GLC NS NS NS NS 1 
ALB NS NS NS NS NS 1 
TP NS NS NS NS NS 0,53 1 
TC NS NS NS NS NS NS NS 1 
TG NS NS NS NS NS NS NS 0.60 1 
RBC ~.51 NS NS NS NS NS NS NS NS 1 
Hb NA NS NS NS NS NS NS NS NS 0.74 
Fb NA NS NS NS NS NS NS 0.58 0.57 NS 
CFN NA NS NS NS NS NS NS NS NS NS 
IJT NA NS NS NS NS NS NS NS NS NS 
NFC NA NS NS NS NS NS NS NS NS NS 
BMI NS NS NS NS NS NS NS 0.60 0.55 NS 
NS : Non-significant; Significant (p>O.S) 
Hb Fb CFN IJT NFC BMI 
I 
I 
1 
NS 1 
NS NS 1 
NS ~,54 NS 1 
NS 0.74 NS -0.78 1 
NS 0.55 NS NSW 0.95 1 
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In Table 4.8 Spearman's correlation coefficients of the variables that correlated 
with one another in the group of urbanized black women are given. The 
following positive correlations were found: between serum LH and FSH, 
serum ALB and both TP and TG, between RBC and both Hb and NFC and 
between plasma fibrinogen and NFC. Negative correlations were found 
between LH and CFN, between TC and IJT, between TG and Fb and 
between IJT and NFC. 
In Table 4.9 Spearman's correlation coefficients of the variables that correlated 
with one another within the group of white women are given. The following 
positive correlations were found: between LH & FSH, between ALB & TP, 
TC correlated with TG, Fb & BMI, between TG and both Fb & BMI, between 
RBC & Hb, between Fb and both NFC & BMI and between NFC and BMI. 
Negative correlations occurred between E2 & RBC, between Fb & IJT and 
between IJT & NFC. 
54 
© Central University of Technology, Free State
CHAPTERS 
DISCUSSION, CONCLUSIONS & RECOMMENDATIONS 
5.1 INTRODUCTION & LIMITATIONS OF THE STUDY 
Although the discussion in this Chapter will focus on specific variables, variables 
will also be considered together in their totality in order that a holistic 
approach be used to extrapolate the findings of this study to the main 
objectives. The major problem associated with the interpretation of the results 
are hidden within the fact that the word "socio-economic status" could be very 
controversial, as no quantitative value could be ascribed directly to it other 
than the years and percentage lifetime spent living in an urban area. This 
also indicates that, personal interpretation could play 
discussion, and may lead to unwanted speculation. 
dissertation will guard against this. 
a major role in the 
The writer of this 
The literature (Markowe et aI., 1985; Brunner et aI., 1999) describes that socio-
economic background is considered as a major factor leading to either 
metabolic abnormalities or protective properties related to specific factors 
within the environment of the individual. The aim of this study was to 
investigate the possible effect of different levels of socio-economic status on 
fibrin network architecture in three groups of women - less urbanized black, 
urban black and white. The rationale behind this was mainly ascribed to 
literature describing the effect of socio-economic status on fibrinogen 
concentration. It is described that any factor having an effect on fibrinogen 
concentration (M0l1er & Kristensen, 1991), should have a direct effect on 
fibrin network architecture. Results from this study could be used to 
determine the degree to which this theory can be proven in practice. The 
value of this work lies in the fact that it may open new perspectives for 
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biomedical technology as scientific method of investigation, as well as within 
the normal day-to-day clinical practice used as a diagnostic tool. 
In order to evaluate the true effect of socio-economic status on fibrin network 
architecture, a study of epidemiological nature including large numbers of 
subjects would be preferred. This study can be classified as a preliminary 
study opening doorways to futu~e investigations. 
Studies investigating the health of women in developing countries have largely 
been focused on maternal nutrition. Little attention has been paid to the well-
being of women and their health status, including the effect of nutrition, 
physical performance and social and economic activities (Goldberg, 1997). 
Some developing countries are experiencing an epidemiological tranSition , 
with a move from infectious diseases and undernutrition to chronic diseases 
such as hypertension and diabetes as the most important cause of morbidity 
and mortality (Walker, 1997). The variation between rural and urban areas 
and among social classes will affect the nutritional issues of most relevance to 
women. The main issues for more affluent women in these countries or for 
the majority of women in countries in transition are probably similar to those of 
women in developed countries. 
South Africa can be regarded as a developing country, but differs from other 
developing countries in the sense that large parts of the country, as well as 
certain population groups, are technologically highly developed. At present 
rapid urbanization from rural areas where traditional ethnic lifestyles 
previously persisted, are now taking place. The detrimental effects of 
urbanization on dietary patterns, nutrient intakes and nutritional status 
(Popkin, 1994), lifestyle changes (Yach et aI., 1990), risk of stroke (Seedat et 
aI., 1982), diabetes mellitus (O'Dea et aI., 1990; Levitt, 1997), coronary heart 
disease risk factors (Steyn et aI., 1991; Slabber et aI., 1996) and others have 
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been described in South African as well as in international literature. The low 
prevalence, on the other hand, of colon (Walker, 1996) and breast cancer 
among African populations (Walker & Burger, 1997), as well as the rarity of 
hip fractures in sub-Saharan Africans (Schnitzler et aI. , 1996) can possibly 
also be ascribed to lifestyle. Iron deficiency, which has been rare in 
traditional African women, has also increased during the last decades (Patel 
et al., 1992). On the other hand, the beneficial effects of urbanization such 
as an increased life expectancy, lower incidence of undernutrition, decreased 
infant mortality rates and increased quality of life have also been described 
(Jimenez, 1993; Shi, 1993). 
In the Free State Province it has been shown that urbanization has already 
taken place on a large scale, and that little difference exists in the disease 
risk prevalence of urbanized and so-called semi-urbanized and rural 
populations (Mollentze et al., 1995). 
In this study, a group of women was selected according to strict inclusion 
criteria. One of the most important criteria, having a very significant effect on 
the results, stated that all volunteers should be apparently healthy. This was 
also confirmed by a medical examination performed by a registered general 
practitioner. It also implicates that all detrimental effects of socio-economic 
status were not allowed to follow their normal route within the subjects. 
Consequently, the effect of factors such as HIV status, the prevalence of 
tuberculosis, smoking habits, alcohol intake etc., which could be considered 
as part of socio-economic status, were excluded from this study. From this it 
can be reasoned that the true effect of socio-economic status is not reflected 
within the results of this study. This is, however, not true. It is rather a 
limitation with reason. 
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It was considered as important to use diseases of lifestyle as an exclusion factor 
in order to prevent skewing of results due to associated expected high levels 
of plasma fibrinogen. Plasma fibrinogen is an acute phase protein (Dippel , 
1992). Thus, any metabolic abnormality evoking an acute phase response 
would cause a natural increase in plasma fibrinogen concentration (Resch & 
Emst, 1994). This will directly have an influence on the fibrin network 
architecture variables and would result in leading of the conclusions made 
from them. A good example of this would be, for instance, individuals living 
with HIV/AIDS. Patients living with HIV/AIDS have abnormal coagulation 
profiles, which are associated with severe Rouloux or red cell aggregation, 
elevated erythrocyte sedimentation rate and elevated plasma viscosity (Lowe, 
1993). Not only HIV/AIDS, but also a variety of other metabolic abnormalities 
associated with lifestyle, have very specific and profound effects on 
coagulation profiles of individuals. These abnormalities include, for instance, 
diabetes mellitus (Ganda et aI., 1992), tuberculosis, obesity (Vorster et aI. , 
1989; Lip, 1995), hypertension (Kannel, 2000), hypertriglyceridaemia (Halle 
et aI., 1996), etc., all of which were excluded in this study. In this way, the 
influence of socio-economic status as determined by years spent living in an 
urban area on fibrin network architecture could be evaluated. 
5.2 METABOLIC VARIABLES 
It was evident that there were no major unexpected differences between the 
metabolic variables of the three different subject groups. All the subjects 
within the three groups were apparently healthy individuals, without any 
previously diagnosed disease states, such as hypercholesterolaemia, glucose 
intolerance, high blood pressure, etc. It is commonly believed that a more 
prudent lifestyle should be associated with a "healthy" metabolic profile . In 
this case, prudent is defined by low stress levels, healthy food intake (such as 
adequate dietary fibre, vitamin and mineral intake) , adequate phYSical 
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exercise, etc. The question may be asked if any of the subject groups used in 
this study could be classified as "prudent lifestyle" individuals, also in South 
Africa "urbanization" does not necessarily mean better socio-economic 
circumstances. This is most probably not the case. It can be reasoned that a 
prudent lifestyle is more of an idealistic end-point. 
Most variables that differed significantly between the different subject groups 
could not only be ascribed to the difference in socio-economic background, 
but may also be ascribed to genetiC differences between the two groups of 
races used as subjects within this study. A variety of studies (Folsom et al., 
1993; Bao et aI., 1993) have shown that ethnic differences exist in some 
metabolic parameters. The Department of Chemical Pathology at the UFS 
found that there is a significant difference in the total protein levels and sub-
protein levels of the black and white population of the Free State Province 
(unpublished data). This study in the early 1980's concluded that the TP 
levels of the South African black population were lower than that of the white 
population. Subjects in this study were also apparently healthy. In the 
current study exactly the opposite was found. A variety of questions may now 
be asked, including the question related to an overall change in socio-
economic status as undergone by the black population from 1980 to 2001, 
and its overall effect on the health status of these individuals. Can 
urbanization and its associated effect on diet, lifestyle, activity levels, etc. 
contribute to these major changes? This question may be answered in 
another study. 
One major difference between the different subject groups was found to be 
associated with serum hormonal levels, however, these differences were of no 
clinical significance. Both the mean LH and mean FSH levels of the white 
women were lower than that of the two black groups. The mean LH level of all 
three the groups were normal , while the mean FSH level of the two black 
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groups were elevated. Although the mean estradiol values of all three the 
groups were normal, there was a 45% difference between the mean values of 
the urbanized and less urbanized black women. However, this difference was 
of no clinical significance. The mean progesterone level of the two black 
groups were slightly lower than that of the white group and were also slightly 
below the normal ranges for day 21-30 of the menstrual cycle. A variety of 
socio-economic factors may play an important role regarding this aspect. 
Factors such as the number of pregnancies (Yin et aI., 1998), the use of birth 
control agents (Folsom et aI., 1993; Lip, 1995), hormone replacement 
(Gebara et aI., 1998) etc. are all factors that are partially determined by a 
blend of social and cultural factors which should in return have a direct 
influence on the metabolic markers in blood. It is not possible to speculate on 
the specific factors such as religion and cultural beliefs within each culture 
that may influence these markers. 
The next issue addresses the relevance of these minor differences and changes 
in metabolic parameters that took place over time, to the "change" in health 
status of these individuals. A quantitative survey using information from 
public health systems would have to be performed in order to assess if a true 
change in health status of the different population groups investigated in this 
study exists. Would a change in one metabolic variable such as TP have a 
Significant impact on the health status of the individual? It can be speculated 
that the observed differences hint only for a tendency to change, and that 
these changes have not yet taken place completely. It is unknown what time 
such changes will need to take place and if these changes are expected. 
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5.3 HAEMATOLOGICAL VARIABLES 
However unsuspected, there were no major differences between haematological 
variables "listed" as lifestyle sensitive. Haematological variables are 
sometimes difficult and intriguing to interpret. The main problem with 
haematological studies could mainly be ascribed to the fact that when the 
results are put into perspective, there are always other variables excluded 
from the study which may have been worth analyzing for interpretation 
purposes. The most limiting factor when deciding on a variable pool is most 
probably financial constraints. Haematological parameters are extremely 
expensive and usually labor intensive. For this reason, all results from 
haematological studies should be interpreted with utmost care. Also, these 
results should be interpreted taking the methodological techniques into 
consideration, i.e. immunological methods giving exact values, physiological 
or enzymatic methods giving derived values, etc. 
In this study there were no major statistical differences in the haematological 
variables of the three different study groups. However, it is important to 
discuss the tendency of each group to differ from each other. 
The haemoglobin values of both the urban and less urbanized black women 
were lower than that of the white group. However, this is of no clinical 
significance. The differences between the haematological values for different 
races have been well described (Cross et al., 1983). In this study, the group 
of less urbanized black women had fibrinogen values higher than those of the 
white women, but lower than those of the urban black women. This difference 
between fibrinogen levels of the black and white women was expected 
(Folsom et al., 1993). In correlation with this study, James et al. (2000) 
reported an increase in the plasma fibrinogen levels with urbanization. The 
urban black females had the highest plasma fibrinogen levels. It is also 
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interesting to note that the concentration falls above the upper limit set for 
plasma fibrinogen (4.0 gIL). The clinical significance of this is in question. It 
is expected that a similar plasma fibrinogen level that seems high for one 
group of subjects, may not be high for another group of subjects. It also 
seems that the risk for development of any disease associated with raised 
plasma fibrinogen may not depend on the concentration of the circulating 
protein alone, but also some other factors within the direct surroundings of the 
protein. This is why fibrin network architecture is such a good method 
describing the qualitative effect of the direct surroundings on the fibrinogen 
molecule and the resulting clotting process the molecule undergoes to form 
the final fibrin product. At this stage the information leading to this 
"hypothesis" is not proven yet, but results from previous studies (Veldman et 
aI., 1999) leads the way to this school of thought. 
Results from this study indicated that between the three different groups of 
subjects, the group of white women had the healthiest network structures 
related to the mass-to-Iength ratio of the fibrin fibres, also associated with the 
fastest rate of network lysis (Gabriel et aI., 1992). This relationship between 
mass-to-Iength ratio should be expected due to the fact that lysis rate mostly 
depends on the surface area of the fibrin fibres available for cleavage to the 
fibrinolytic enzymes (Gabriel et aI., 1991). Fibrin, with its ordered structure 
appears to exert its rate-enhancing effect by presenting its binding-sites for 
interaction with tPA and plasminogen, thus concentrating and correctly 
orienting these two reactants on its surface and inducing conformational 
changes which lead to higher catalytic efficiencies (Nieuwenhuizen, 1994). 
The compaction of the fibrin networks of the white and urban black women 
was very close and was higher than that of the less urbanized black group. 
This also indicates that the white and urbanized groups have healthier fibrin 
network structures. These "healthier" networks are rendered less ridged and 
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more porous, which leaves the structures more plastic and deformable, and 
therefore the structures are believed to be less atherogenic. 
5.4 CONCLUSION 
The results of this study can be very useful for future references dealing with the 
effect of socio-economic factors on human metabolism and its different sub-
divisions. This study originated from published data (Brunner et aI., 1999; 
M011er & Kristensen, 1991) which suggests that socio-economic status has a 
direct influence on plasma fibrinogen levels in human subjects. This study 
implies that the metabolic abnormalities associated with different levels of 
socio-economic status are not necessarily associated with socio-economic 
class itself, but rather with the associated factors related to the different levels 
of socio-economic status, such as the prevalence of tuberculosis, HIV, 
diabetes mellitus, hypercholesterolaemia, etc., which were exclusion criteria 
in this study. These diseases of lifestyle are all abnormalities that are more 
frequent within specific socio-economic groups of the population (Brunner et 
aI., 1999; Marmot et aI., 1991). The study showed that there is a specific 
tendency towards differences in the metabolic variables, especially the 
hematological variables and associated fibrin network architecture variables. 
However, this "tendency" is not of statistical or clinical significance. Also, the 
study group was very small and this may contribute to the non-significance of 
the results. 
In conclusion, the results from this study indicate that a small difference in the 
fibrin network architecture of individuals from different socio-economic 
background does exist. However, it also seems that if the individual is 
relieved from the burden associated with specific socio-economic 
backgrounds, we eventually seem all to inherit the same health status. 
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5.5 RECOMMENDATIONS 
The results from this study clear1y under1ine the need for further investigation. 
Prospective epidemiological trials would be helpful to evaluate the true effect 
of socio-economic variables and associated conditions on metabolic risk 
factors. A cohort design would be the method of preference. A much larger 
group of subjects should also be included in the study. Two questions 
should clearly be distinguished: 
- What is the effect of a change in socio-economic status on the health of 
an individual, i.e. movement of an ·individual from a rural to an urbanized 
background, and 
What is the static/baseline effect between different levels of socio-
economic status on the health of different individuals, i.e. people bom in 
different levels of socio-economic status and growing up within that 
specific surrounding? 
Major factors influencing general public health related to socio-economic status 
that need urgent attention include the role of peer pressure, advertising, 
government health regulations on consumer products, school feeding 
programmes and general nutrition education, as well as the knowledge of 
the general public concerning the products they consume. It will not be easy 
to evaluate the specific role of these factors on individual health. However, 
without this information it would not be possible to distinguish between 
different levels of socio-economic background and its effect on the health of 
the individuals living in these societies. 
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APPENDIX A 
BIOCHEMICAL VARIABLE UNITS AND NORMAL RANGES 
,VARIABLE UNITS · NORMAL RANGE 
.' ". ," " 
, ." 
BMI kg/m' 18.5 - 25 
E2 pmol/L 121 - 551 
LH lUlL 0.5-17 
FSH lUll 1-9 
Prog nmol/L 10-89 
GLC mmol/L 3.6 -5.6 
ALB gIL 35-52 
TP gIL 60-82 
TC mmollL 4.1-6.2 
TG mmol/L 0.40-2.26 
RBC 10"6/IJL 4.2 - 5.2 
Hb g/dL 11.5-16.5 
Fb gIL 1.5-4.0 
CFN % Not established 
IJT Oa/cm x 10'2 Not established 
NFC gIL Not established 
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APPENDIX B 
FIBRINOGEN AND FIBRIN NETWORK STUDIES 
ON PRE-MENOPAUSAL WOMEN 
SOCIO·ECONOMIC STATIJS AND PERSONAL 
INFORMA nON 
Name: 
-------
Respondent number: 
Birth date. 
Interview date. 
Address: _____ _ 
Telephone number: _ ____ _ 
I. Do you drink alcoholic beverages? 
DOD 1-3 
000000004-11 
0000000012-19 
Yes (1) No (2) 0 20 
2. How often do you usually drink alcohol? 0 21 
1. Every day. 
2. 5-6 Days per week. 
3. 3-4 days per week. 
4. 1-2 days per week. 
5. Weekends. 
6. Less than once a week. 
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3. On a weekday when you do drink alcohol, 
how many drinks do you usually have per day? 
1. Beer (bottles/cans) 
2. Brandy/whisky (tots) 
3. Vodka/Gin (tots) 
4. Sherry/Sweet wine (glasses) 
5. Table wine (glasses) 
6. Other, please specifY 
4. On a weekend day when you drink alcohol, 
how many drinks do you usually have? 
1. Beer (bottles/cans) 
1. Brandy/whisky (tots) 
2. Vodka/Gin (tots) 
3. Sherry/Sweet wine (glasses) 
4. Table wine (glasses) 
5. Other, please specifY 
5. Is there a family history of chronic disease? 
Yes (1) No (2) 
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6. If yes, please specifY 
1. Diabetes 
2. Heart disease 
3. High or low blood pressure 
4. TB 
5. Other, please specify 
7. Weight (kg) 
8. Length (m) 
9. How long (years) have you been living 
in an urban area like Mangaung or 
Bloemfontein? 
10. Do you smoke? Yes (I) No (2) 
o 47 
0 48 
0 49 
0 50 
0 51 
000.052-55 
0.0056-58 
DO 59-60 
061 
II. What is your highest level of education? 0 62 
1. None 
2. Primary School 
3. Std 6-8 
4. Std 9-10 
5. Tertiary Education 
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12. Employment status. 063 
1. Housewife by choice 
2. Unemployed 
3. S elf employed 
4. Full time wage/salary earner 
5. Other, please specifY 
6. Don't know 
13. How many days per week do you work? 064 
14. How long per day do you work (min)? 00065-67 
15. Do you play sport? Yes(l) No(2) 068 
16. If yes, which type of sport? ___ _ DO 69-70 
17. How long do you practice per week (min)? DOD 71-73 
18. Do you have leisure time? Yes(l) No(2) 074 
19. If yes, do you 
1. Do sitting activities 
2. Do you walk 
3. Do you do standing activities 
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20. Do you follow any special diet? 
Yes(l) No(2) 076 
21. If yes, please specifY 077 
1. Diabetic 
2. Slimming 
3. Allergies 
4. Other, please specifY _____ _ 
22. Do you take any Vitamin supplements? 
Y es(l) No(2) 078 
23. Indicate which of the following best 0 79 
describes the eating pattern you usually follow. 
I . More than 3 meals per day with eating between meals. 
2. 3 Meals per day with eating between meals. 
3. 3 Meals per day with no eating between meals. 
4. 2 Meals per day with eating between meals. 
5. 2 Meals per day with no eating between meals. 
6. I Meal per day with eating between meals. 
7. 1 Meal per day with no eating between meals. 
8. Nibble the whole day, no specific meals. 
9. Other, please specifY _____ _ 
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APPENDIX C 
CONSENT FORM (Black women: Mangaung) 
The association between levels of socio-economic status and fibrin 
networ1t architecture in women aged between 35 and 44 years 
Declaration by or on behalf of the participant: 
Respondent number DOD 
I, the undersigned, 
[10 .. ... .. .. .... ......... ........ .......... ) 
.................................... ....... ........ ......... ............... ......... ........ .... (address) 
A confirm that: 
1. I have been asked to participate in the research survey: Nutritional Health of 
Women (25-44 years) in Mangaung, 2000. The Technikon Free State and 
University of the Orange Free State will carry out this study. I also understand 
that if my results of the above mentioned study meets certain criteria, my blood 
will also be used to take part in another study carried out by the Technikon Free 
State namely: The association between levels of socio-economic status and 
fibrin network architecture in women aged between 35 and 44 years. 
2. It has been explained to me that: 
2.1 The purpose of the first research survey is to collect information on usual food 
intake, activity level, attitude towards health, risk for developing illnesses related 
to eating habits and lifestyle of women in the ages 25 to 45 years in Mangaung. 
The information collected will be used to determine nutritional problems and to 
develop solutions for these problems. The purpose of the second research 
survey is to collect information on my hormonal status, to determine may socio-
economical status, and to determine the influence of this on fibrinogen 
concentration and on fibrin networks, risk for developing illnesses related to the 
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altered fibrinogen concentration and the changes in fibrin networks. The 
information collected will be used to determine the relation between socio-
economical status and the risk for cardiovascular heart disease and possible 
preventative measures for higher risk of CHD. 
2.2 In order to collect this information for these two studies I have been told that I 
will be asked a number of questions regarding: 
• general background information; 
• the types and amounts of foods I eat and how often I eat these foods; 
• how active I am every day; 
• my attitude towards leanness and fatness; 
• general knowtedge on my menstrual cycle, contraception, pregnancy and breast 
cancer. 
2.3 I also understand that a medical doctor will perform a free medical examination 
and that blood samples will be drawn by a registered nurse. One of these blood 
samples will include a test for HIV-AIDS. I also agree to be weighed and 
measured. I will not eat or drink anything after 10:00 of the evening preceding 
the research day, I will be given some tea and sandwiches after I have been 
weighed, measured and the blood have been collected. I will bring a list of the 
medication that I usually use with me on the research day. 
2.4 I have been told that this information will be collected from over 500 women in 
Mangaung and on 30 female staff members of the Technikon Free 
State and that these questions will only be asked once. The measurements and 
blood samples will also be taken once only. 
2.5 I have been told that it will not take more than one day to collect the information . 
I understand that on this day I will be measured, weight, urider go a medical 
examination, and answer questions in order to complete five questionnaires. 
There will also be blood taken from me, but no more than 20 ml. 
3 I have been told that the measurements will not cause any harm to me in any 
way. 
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4 It was also explained to me that by participating in the research survey I will help 
other women in the country. 
5. It was also explained to me that the information will be kept confidential but that 
it will be used anonymously (subject numbers will be assigned to each 
participant) for making known the findings to other scientists. 
6. I understand that I will have no direct access to the results of the survey but I 
can contact the researcher who will inform me of the findings. It was also 
explained to me that if I want my HIV results, I will only be able to get them from 
the medical doctor who did the medical investigation, she will also assist me 
with any questions I might have regarding the result of the HIV test. 
7. It was also clearly explained to me that I could refuse to participate in this 
research survey. If I refuse, it will not be held against me in any way. 
8. The information in this consent form was explained to me by 
.. ... .... ... .... .... . (name of interviewer) in ..... . ....... ... .. .... ... (Ianguage) and I 
confirm that I have a good command in this language and understood the 
explanations. I was also given the opportunity to ask questions on things I did 
not understand clearly. 
9. No pressure was applied on me to take part in th is research survey. 
10. Finally, after completion of my participation in this research survey I will receive 
a payment of R40. I will be responsible for my own transport home. 
B I hereby agree voluntarily to take part in this research survey. 
Signed/confirmed at ...... .. ...... ....... .. ................................. . on ......... .. ... 2000 
Signature or hand mark of 
Participant 
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APPENDIX D 
CONSENT FORM (Staff: Technikon Free State) 
The association between levels of socio-economic status and f ibrin 
network architecture in women aged between 35 and 44 years. 
Declaration by or on behalf of the participant: 
Respondent number 000 
I, the undersigned, 
[10 .............. ... ..... ...... .. .... .. .... ] 
.. ....... .. ..... .... .... .... ... ... ... ... ........ .. ..... ... .. ............. .. ..... ......... ....... (address) 
A confirm that: 
1. I have been asked to participate in the research survey carried out by the 
Technikon Free State namely: The association between levels of socio-
economic status and fibrin network architecture in women aged between 35 and 
44 years. 
2. It has been explained to me that: 
2.1 The purpose of the research survey is to collect information on my hormonal 
status, on my soCio-economic status, and to determine the influence of this on 
fibrinogen concentration and on fibrin networks, risk for developing illnesses 
related to the altered fibrinogen concentration and the changes in fibrin 
networks. The information collected will be used to determine the relation 
between socio-economic status and the risk for cardiovascular heart disease 
and possible preventative measures for higher risk of CHD. 
2.2. In order to co llect th is I have been told that I will be asked a number of 
questions regarding: 
• general background information ; 
• how active I am every day; 
• my attitude towards leanness and fatness; 
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• general knowledge on my menstrual cycle, contraception, pregnancy and breast 
cancer. 
2.3 I also understand that a medical doctor will perfonm a free medical examination 
and that blood samples will be drawn by a registered nurse. One of these blood 
samples will include a test for HIV-AIDS. I also agree to be weighed and 
measured. I will not eat or drink anything after 10:00 of the evening preceding 
the research day, I will be given some tea and sandwiches after I have been 
weighed, measured and the blood have been collected. I will bring a list of the 
medication that I usually use with me on the research day. 
2.4 I have been told that this infonmation will be collected from over 500 women in 
Mangaung and on 30 female staff members of the Technikon Free 
State and that these questions will only be asked once. The measurements and 
blood samples will also be taken once only. 
3. I have been told that it will not take more than one day to collect the infonmation. 
I understand that on this day I will be measured, weighed and answer a number 
of questions to complete the questionnaires. I also know that blood will be 
taken from me, but no more than 20 ml. I have been told that the 
measurements will not cause any harm to me in any way. 
4 It was also explained to me that by participating in the research survey I will help 
other women in the country. 
5. It was also explained to me that the infonmation will be kept confidential but that 
it will be used anonymously (subject numbers will be assigned to each 
participant) for making known the findings to other scientists. 
6. I understand that I will have no direct access to the results of the survey but I 
can contact the researcher who will infonm me of the findings. It was also 
explained to me that if I want my HIV results, I will only be able to get them from 
the medical doctor who did the medical investigation, she will also assist me 
with any questions I might have regarding the result of the HIV test. 
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7. It was also clearly explained to me that I could refuse to participate in this 
research survey. If I refuse, it will not be held against me in any way. 
8. The information in this consent form was explained to me by 
...... ......... ...... (name of interviewer) in ......... ....... ......... (Ianguage) and I 
confirm that I have a good command in this language and understood the 
explanations. I was also given the opportunity to ask questions on things I did 
not understand clearly. 
9. No pressure was applied on me to take part in this research survey. 
B I hereby agree voluntarily to take part in this research survey. 
Signed/confirmed at ..... ..................... ... ...... ..... ... ..... ......... on ..... ......... 2000 
Signature or hand mark of 
Participant 
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